Volume 240, Issue 9

Search all Psychopharmacology articles

September 2023

15 articles in this issue

Therapeutic potential of NOX inhibitors in neuropsychiatric disorders
Parneet Kaur
Heena Khan
Thakur Gurjeet Singh
Review 28 July 2023 Pages: 1825 - 1840
Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy
Doodipala Samba Reddy
Robert H. Mbilinyi
Emily Estes
Review Open access 11 August 2023 Pages: 1841 - 1863
Neuroprotective effect of salidroside on hippocampal neurons in diabetic mice via PI3K/Akt/GSK-3β signaling pathway
Xue-Hua Wang
Zhong-Fu Zuo
De-Yu Zheng
ORIGINAL INVESTIGATION 25 July 2023 Pages: 1865 - 1876
Potential antidepressant-like effects of N-3 polyunsaturated fatty acids through inhibition of endoplasmic reticulum stress
Mimi Tang
Ting Liu
Tao Yin
Original Investigation 23 August 2023 Pages: 1877 - 1889
Methamphetamine alters nucleus accumbens neural activation to monetary loss in healthy young adults
Natania A. Crane
Hanna Molla
Harriet de Wit
Original Investigation 02 August 2023 Pages: 1891 - 1900
Smoking reduction using electronic nicotine delivery systems in combination with nicotine skin patches
Jed E. Rose
Suzanne Frisbee
James M. Davis
Original Investigation Open access 17 July 2023 Pages: 1901 - 1909
Comparison between olanzapine and aripiprazole treatment for 104 weeks after hospital discharge in schizophrenia spectrum disorders: a multicenter retrospective cohort study in a real-world setting
Tomonari Hosokawa
Chikara Miyaji
Norihito Yamada
Original Investigation 17 July 2023 Pages: 1911 - 1920
Are medication effects on subjective response to alcohol and cue-induced craving associated? A meta regression study
Lara A. Ray
Steven J. Nieto
Han Du
Original Investigation Open access 15 July 2023 Pages: 1921 - 1930
Atypical antipsychotics attenuate MK801-induced social withdrawal and hyperlocomotion in the RHA rat model of schizophrenia-relevant features
Daniel Sampedro-Viana
Toni Cañete
Alberto Fernández-Teruel
Original Investigation 13 July 2023 Pages: 1931 - 1945
18β-glycyrrhetinic acid ameliorates MPTP-induced neurotoxicity in mice through activation of microglial anti-inflammatory phenotype
Hanyue Luo
Caishi Zhang
Wei Yao
Original Investigation 12 July 2023 Pages: 1947 - 1961
No benefit of antidepressants in inpatient treatment of depression. A longitudinal, quasi-experimental field study
Reinhard Maß
Kerstin Backhaus
Bodo K. Unkelbach
Original Investigation Open access 01 August 2023 Pages: 1963 - 1971
Poor inhibitory control predicts sex-specific vulnerability to nicotine rewarding properties in mice
Maria-Carmen Medrano
Florence Darlot
Stephanie Caille
Original Investigation 13 July 2023 Pages: 1973 - 1986
Sex differences in acute delta-9-tetrahydrocannabinol (Δ⁹-THC) response and tolerance as a function of mouse strain
Courtney F. Lulek
Malabika Maulik
Angela N. Henderson-Redmond
Original Investigation Open access 29 July 2023 Pages: 1987 - 2003
Sprague Dawley rats from different vendors vary in the modulation of prepulse inhibition of startle (PPI) by dopamine, acetylcholine, and glutamate drugs
S.B. Caine
S. Plant
M. Thomsen
Original Investigation Open access 14 August 2023 Pages: 2005 - 2012
Dukak – a pathognomonic symptom of khat withdrawal?
Benjamin Swart
Letter to Editor 31 July 2023 Pages: 2013 - 2014

Volume 240, Issue 9

Therapeutic potential of NOX inhibitors in neuropsychiatric disorders

Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy

Neuroprotective effect of salidroside on hippocampal neurons in diabetic mice via PI3K/Akt/GSK-3β signaling pathway

Potential antidepressant-like effects of N-3 polyunsaturated fatty acids through inhibition of endoplasmic reticulum stress

Methamphetamine alters nucleus accumbens neural activation to monetary loss in healthy young adults

Smoking reduction using electronic nicotine delivery systems in combination with nicotine skin patches

Comparison between olanzapine and aripiprazole treatment for 104 weeks after hospital discharge in schizophrenia spectrum disorders: a multicenter retrospective cohort study in a real-world setting

Are medication effects on subjective response to alcohol and cue-induced craving associated? A meta regression study

Atypical antipsychotics attenuate MK801-induced social withdrawal and hyperlocomotion in the RHA rat model of schizophrenia-relevant features

18β-glycyrrhetinic acid ameliorates MPTP-induced neurotoxicity in mice through activation of microglial anti-inflammatory phenotype

No benefit of antidepressants in inpatient treatment of depression. A longitudinal, quasi-experimental field study

Poor inhibitory control predicts sex-specific vulnerability to nicotine rewarding properties in mice

Sex differences in acute delta-9-tetrahydrocannabinol (Δ⁹-THC) response and tolerance as a function of mouse strain

Sprague Dawley rats from different vendors vary in the modulation of prepulse inhibition of startle (PPI) by dopamine, acetylcholine, and glutamate drugs

Dukak – a pathognomonic symptom of khat withdrawal?

Navigation